We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Genomic Duplication Responsible for Rare Skin Disease

By LabMedica International staff writers
Posted on 15 May 2017
Print article
Image: A biopsy from the sole of the foot showing a recovered granular layer and a layer of parakeratosis sandwiched between the old orthokeratotic stratum corneum and a re-established orthokeratotic layer (Photo courtesy of SAMJ).
Image: A biopsy from the sole of the foot showing a recovered granular layer and a layer of parakeratosis sandwiched between the old orthokeratotic stratum corneum and a re-established orthokeratotic layer (Photo courtesy of SAMJ).
Through data analysis, ancestry mapping, genomic comparison, and international collaboration, researchers have identified the genetic mutation that causes the rare skin disease keratolytic winter erythema (KWE), or “Oudtshoorn skin,” in South African and Norwegian families.

Researchers at University of the Witwatersrand led the study in collaboration with peers in Europe, the USA, and Canada. KWE causes a redness of the palms and soles with consecutive cycles of peeling of large sections of thick skin, often exacerbated during winter months. Oudtshoorn is a town in the Western Cape province of South Africa where the disorder was present in large families.

Afrikaners, the Afrikaans-language speakers descended from predominantly Dutch, German, and French settlers in South Africa, have a high risk for several genetic disorders (e.g. familial hypercholesterolaemia, porphyria, and the lesser known KWE) because of founder mutations brought by small groups who settled in the Cape of Good Hope and whose descendants are now spread throughout South Africa.

In 1977 KWE was found to occur with a dominant mode of inheritance (so, on average, if a parent has the condition about half the children inherit it in every generation). This early research has enabled dermatologists to make a definitive diagnosis and helped researchers better understand similar skin disorders.

In 1997, student Michelle Starfield guided by Michèle Ramsay, professor at Witz, and a group in Germany mapped the KWE trait to a region on the short arm of chromosome 8. The researchers showed that it was likely that the South African families all had the same mutation but that the German family had a different mutation. Later research focused on characterizing this region of the genome and examining good candidate genes. The KWE mutation remained elusive.

Subsequently, Wits student Thandiswa Ngcungcu, supervised by Prof. Ramsay, investigated KWE with large-scale DNA sequencing during an internship in Novartis, Basel. The mutation was not detected by conventional data analysis so copy-number variants (duplications or deletions) were investigated. Ngcungcu and colleagues discovered a duplication mutation in a genomic region between genes that was present in all South African KWE-affected individuals studied.

During this time Dr Torunn Fiskerstrand, University of Bergen, Norway, independently discovered a genomic duplication as the cause KWE in Norwegians. Ramsay and Fiskerstrand collaborated. The different DNA duplications in the South African and Norwegian families overlapped at a critical enhancer region, providing strong evidence that this was the KWE-causing mutation.

The scientists researched how this duplicated enhancer caused KWE and discovered that the mutation causes a nearby gene, CTSB, to produce more protein than normal and that this abnormal expression was the likely cause of the skin peeling disorder.

The study, by Ngcungcu T et al, was published in the May 2017 issue of the American Journal of Human Genetics.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.